Role of lung and gut microbiota on lung cancer pathogenesis Yue ZhaoYuxia LiuXin Zheng Review – Cancer Research Open access 20 May 2021 Pages: 2177 - 2186
Aurora B kinase: a potential drug target for cancer therapy Azaj AhmedAnas ShamsiMd. Imtaiyaz Hassan Review – Cancer Research 28 May 2021 Pages: 2187 - 2198
Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence? Abdul Arif Khan Review – Cancer Research 11 June 2021 Pages: 2199 - 2207
Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer Yu ZhangFei WangHua Huang Original Article – Cancer Research 23 April 2021 Pages: 2209 - 2222
Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation Mohammed AlshalalfaHatem Abou-OufTarek A. Bismar Original Article – Cancer Research 16 April 2021 Pages: 2223 - 2231
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer Tilman D. RachnerSabine Kasimir-BauerAnn-Kathrin Bittner Original Article – Cancer Research Open access 21 April 2021 Pages: 2233 - 2238
The status of WIF1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer Zhijun ShenChen ChenShiguo Liu Original Article – Cancer Research 26 May 2021 Pages: 2239 - 2248
Testicular cancer follow-up costs in Germany from 2000 to 2015 Thomas MichaeliJulia MichaeliDaniel Michaeli Original Article – Cancer Research Open access 22 April 2021 Pages: 2249 - 2258
The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients Jiebin XieYueshan PangXiaoting Wu Original Article – Cancer Research Open access 18 May 2021 Pages: 2259 - 2269
Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma Dorothee HölzlGeorg HutarewTheo F. J. Kraus Original Article – Cancer Research Open access 08 May 2021 Pages: 2271 - 2280
Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling Mariusz BodziochPiotr BajgerUrszula Foryś Original Article – Cancer Research Open access 29 May 2021 Pages: 2281 - 2299
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience Anna IanzaA. Di ChiccoF. Zanconati Original Article – Cancer Research Open access 18 May 2021 Pages: 2301 - 2307
High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence Mukta BasuAmvrin ChatterjeeChinmay Kumar Panda Original Article – Cancer Research 02 June 2021 Pages: 2309 - 2322
The ability of post-chemoradiotherapy DWI ADCmean and 18F-FDG SUVmax to predict treatment outcomes in head and neck cancer: impact of human papilloma virus oropharyngeal cancer status S. ConnorC. SitV. Goh Original Article – Cancer Research Open access 22 June 2021 Pages: 2323 - 2336
Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review Rishi RajGhada ElshimyZin W. Myint Review – Clinical Oncology Open access 22 June 2021 Pages: 2337 - 2347
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV) Tanja HolzheyWolfram PönischMarkus Scholz Original Article – Clinical Oncology Open access 12 January 2021 Pages: 2349 - 2359
Effects of a patient-tailored integrative oncology intervention in the relief of pain in palliative and supportive cancer care Eran Ben-AryeDana EllyAmir Minerbi Original Article – Clinical Oncology 12 January 2021 Pages: 2361 - 2372
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy Eike SteidlKatharina FilipskiOliver Bähr Original Article – Clinical Oncology Open access 04 February 2021 Pages: 2373 - 2383
Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis Hiroyuki OhnumaYasushi SatoJunji Kato Original Article – Clinical Oncology 03 February 2021 Pages: 2385 - 2396
Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer Mingxiang FengXin YeChunxue Bai Original Article – Clinical Oncology Open access 06 February 2021 Pages: 2397 - 2405
Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials Wanting HouMingfu DingCheng Yi Original Article – Clinical Oncology Open access 16 March 2021 Pages: 2407 - 2420
Is the prediction of one or two ipsilateral positive lymph nodes by computerized tomography and ultrasound reliable enough to restrict therapeutic neck dissection in oral squamous cell carcinoma (OSCC) patients? Karl Christoph SprollSabina LeydagJulian Lommen Original Article – Clinical Oncology 01 February 2021 Pages: 2421 - 2433
Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma Jung Ho ImGi Hong ChoiJinsil Seong Original Article – Clinical Oncology 20 January 2021 Pages: 2435 - 2445
Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study Prashanth Ashok KumarShweta PaulrajAbirami Sivapiragasam Original Article – Clinical Oncology 31 January 2021 Pages: 2447 - 2458
Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 Ji Hyun ParkGun Lyung YouJin Hyoung Kang Original Article – Clinical Oncology 01 February 2021 Pages: 2459 - 2469
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities Cyrill WehlingMichael T. DillMarkus Mieth Original Article – Clinical Oncology Open access 04 February 2021 Pages: 2471 - 2481
A novel NECTIN4-NTRK1 fusion identified in a lung squamous cell carcinoma patient with MSI-H Peng LiFeng HouYongjie Wang Letter to the Editor 03 April 2021 Pages: 2483 - 2486
Correction to: Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario Jordan Lerner-EllisChloe MightonGeorge S. Charames Correction 25 September 2020 Pages: 2487 - 2487